Table 2.
Symptoms | Survivors (n = 46) | Non-survivors (n = 29) | P value a |
---|---|---|---|
Dyspnea, n (%) |
12 (26.1) |
14 (48.3) |
.049 |
Fever, n (%) |
46 (100) |
29 (100) |
1.000 |
Nausea, n (%) |
35 (76.1) |
21 (72.4) |
.722 |
Vomiting, n (%) |
27 (58.7) |
17 (58.6) |
.995 |
Anepithymia, n (%) |
12 (26.1) |
4 (13.8) |
.206 |
Hematemesis, n (%) |
5 (10.9) |
2 (6.9) |
.866 |
Dark stools, n (%) |
7 (15.2) |
4 (13.8) |
.865 |
Abdominal distention, n (%) |
23 (50) |
13 (44.8) |
.662 |
Cough, n (%) |
17 (37) |
6 (20.7) |
.137 |
Expectoration, n (%) |
13 (28.3) |
4 (13.8) |
.145 |
Spasm, n (%) |
3 (6.5) |
3 (10.3) |
.875 |
Agitation, n (%) |
16 (34.8) |
24 (82.8) |
< .001 |
Fatigue, n (%) |
21 (45.7) |
10 (34.5) |
.339 |
Lethargy, n (%) |
11 (23.9) |
10 (34.5) |
.323 |
Hemoptysis, n (%) |
2 (4.3) |
2 (6.9) |
1.000 |
Blurred vision, n (%) |
3 (6.5) |
3 (10.3) |
.875 |
Chills, n (%) |
10 (21.7) |
9 (31) |
.367 |
Diarrhea, n (%) |
9 (19.6) |
6 (20.7) |
.906 |
Stomachache, n (%) |
19 (41.3) |
11 (37.9) |
.772 |
Headache, n (%) |
22 (47.8) |
10 (34.5) |
.255 |
Dizziness, n (%) |
13 (28.3) |
9 (31) |
.797 |
Lumbago, n (%) |
30 (65.2) |
14 (48.3) |
.147 |
Chest distress, n (%) |
22 (47.8) |
13 (44.8) |
.800 |
Short breath, n (%) | 22 (47.8) | 17 (58.6) | .362 |
aSurvivors vs. non-survivors.